For research use only. Not for therapeutic Use.
Vepafestinib (TAS0953/HM06; compound 6) is a RET inhibitor (extracted from patent WO2019039439)[1]. Vepafestinib is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
| Catalog Number | I038002 |
| CAS Number | 2129515-96-2 |
| Synonyms | 4-amino-N-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholin-4-ylprop-1-ynyl)pyrrolo[2,3-d]pyrimidine-5-carboxamide |
| Molecular Formula | C26H30N6O3 |
| Purity | ≥95% |
| InChI | InChI=1S/C26H30N6O3/c1-26(9-10-26)32-20(4-3-11-31-12-14-35-15-13-31)21(22-23(27)28-17-29-24(22)32)25(33)30-19-7-5-18(6-8-19)16-34-2/h5-8,17H,9-16H2,1-2H3,(H,30,33)(H2,27,28,29) |
| InChIKey | SFXVRNLGOSAWIV-UHFFFAOYSA-N |
| SMILES | CC1(CC1)N2C(=C(C3=C(N=CN=C32)N)C(=O)NC4=CC=C(C=C4)COC)C#CCN5CCOCC5 |
| Reference | [1]. Hayashi, Kohei, et al. FUSION PROTEIN OF DCTN1 PROTEIN WITH RET PROTEIN. WO2019039439. |
